Aclaris Therapeutics, Inc. (ACRS) Earnings Call Transcripts

20 earnings calls from February 2020 to May 14, 2026

NasdaqGS US Health Care Pharmaceuticals

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. (ACRS) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 20 calls on record spanning February 25, 2020 to May 14, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 20 Aclaris Therapeutics, Inc. earnings call transcripts on record, spanning February 25, 2020 to May 14, 2026. Based on this history, Aclaris Therapeutics, Inc. reports semi-annually. The most recent call on file is dated May 14, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
ACRS
Exchange
NasdaqGS
Country
US
Sector
Health Care
Industry
Pharmaceuticals
Calls on record
20
First call
February 25, 2020
Most recent
May 14, 2026
Reporting cadence
semi-annually
Quarter Date
Company Conference Presentations May 14, 2026 Read transcript
Special Calls Apr 28, 2026 Read transcript
Special Calls Jan 6, 2026 Read transcript
Special Calls Oct 14, 2025 Read transcript
Special Calls Jul 29, 2025 Read transcript
Company Conference Presentations May 16, 2025 Read transcript
Special Calls Nov 18, 2024 Read transcript
Company Conference Presentations Jun 11, 2024 Read transcript
Q1 FY2024 May 7, 2024 Read transcript
Special Calls Nov 13, 2023 Read transcript
Company Conference Presentations Jun 14, 2023 Read transcript
Q1 FY2023 May 8, 2023 Read transcript
Company Conference Presentations Jan 11, 2023 Read transcript
Special Calls Dec 7, 2021 Read transcript
Special Calls Jun 8, 2021 Read transcript
Shareholder/Analyst Calls Jun 3, 2021 Read transcript
Special Calls Jan 19, 2021 Read transcript
Special Calls Jun 17, 2020 Read transcript
Shareholder/Analyst Calls Jun 4, 2020 Read transcript
Q4 FY2019 Feb 25, 2020 Read transcript